RPS6 through the activation of NRF2 causes resistance to antiHER2 drugs in HER2 amplified gastric cancer (GC) models

Autor:	Susana Roselló, J. Castillo, P. Tolosa, Carolina Martínez-Ciarpaglini, Valentina Gambardella, N. Tarazona, F.G. Valiente, T. Fleitas Kanonnikoff, Desamparados Roda, A. Cervantes, B. Garcia Mico, Marisol Huerta
Rok vydání:	2018
Předmět:	0301 basic medicine 03 medical and health sciences 030102 biochemistry & molecular biology Oncology Resistance (ecology) business.industry Cancer research Medicine Cancer Hematology business medicine.disease
Zdroj:	Annals of Oncology. 29:vi31-vi32
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy314.039
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9ff719a11ea39bf42e5581ccb23e61b9 https://doi.org/10.1093/annonc/mdy314.039 Zobrazit plný text záznamu